Ovuloc Tablet contains Ethinyl Estradiol (0.03 mg) and Desogestrel (0.15 mg), a combination of synthetic estrogen and progestin used primarily for oral contraception. Ethinyl Estradiol, a potent estrogen analogue, works synergistically with Desogestrel, a third-generation progestin, to inhibit ovulation, alter cervical mucus, and modify the endometrial lining, thereby preventing fertilization and implantation. This combination effectively reduces the risk of unintended pregnancy when taken as directed. Ovuloc is indicated for women seeking reliable birth control and may also be prescribed for regulation of menstrual cycles, treatment of dysmenorrhea, and management of acne in certain cases. The tablet should be taken orally once daily at the same time each day to maintain consistent hormone levels. Patients with a history of thromboembolic disorders, hormone-sensitive malignancies, uncontrolled hypertension, or liver disease should use this medication cautiously and under medical supervision. Common side effects may include nausea, breast tenderness, headache, and breakthrough bleeding, which often resolve with continued use. Ovuloc Tablet does not protect against sexually transmitted infections. Prior to initiation, a thorough medical evaluation is recommended to assess contraindications and ensure safe use.